Dextran-coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging: evaluation of...

Rising criticism of currently available contrast agents for magnetic resonance imaging, either due to their side effects or limited possibilities in terms of functional imaging, evoked the need for safer and more versatile agents. We previously demonstrated the suitability of novel dextran-coated superparamagnetic iron oxide nanoparticles (SPION^Dex) for biomedical applications in terms of safety and biocompatibility.

In the present study, we investigated the size-dependent cross-linking process of these particles as well as the size dependency of their imaging properties. For the latter purpose, we adopted a simple and easy-to-perform experiment to estimate the relaxivity of the particles. Furthermore, we performed an extensive analysis of the particles' storage stability under different temperature conditions, showing their superb stability and the lack of any signs of agglomeration or sedimentation during a 12 week period.

Independent of their size, SPION^Dex displayed no irritation potential in a chick chorioallantoic membrane assay. Cell uptake studies of ultra-small (30 nm) SPION^Dex confirmed their internalization by macrophages, but not by non-phagocytic cells. Additionally, complement activation-related pseudoallergy (CARPA) experiments in pigs treated with ultra-small SPION^Dex indicated the absence of hypersensitivity reactions.

These results emphasize the exceptional safety of SPION^Dex, setting them apart from the existing SPION-based contrast agents and making them a very promising candidate for further clinical development.